Medicare Enrolled

Dr. William Gillespie, M.D.

Psychiatry · Glendora, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
510 S GRAND AVE STE 200, Glendora, CA 91741
6269141980
In practice since 2006 (19 years)
NPI: 1538238118 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gillespie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gillespie? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gillespie

Dr. William Gillespie is a psychiatry specialist in Glendora, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gillespie performed 5,260 Medicare services across 2,039 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gillespie received a total of $16,946 from 37 pharmaceutical and/or device companies across 1058 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gillespie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in CA $16,946 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,260
Medicare services
Top 1% in CA for psychiatry
2,039
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~277 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
2,218 $66 $119
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
959 $99 $179
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
524 $78 $201
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
498 $108 $204
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
399 $60 $114
Home visit, established patient, straightforward decision making
A home visit for an established patient involving straightforward medical decision making. The visit lasts at least 15 minutes when time is used to determine the level of service.
327 $36 $69
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
281 $68 $123
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
34 $153 $281
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
20 $143 $305
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,946
Total received (2018-2024)
Avg $2,421/year across 7 years
Top 4% in CA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
1,058
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,221 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$725 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,915
2023
$2,473
2022
$1,929
2021
$2,260
2020
$1,818
2019
$2,287
2018
$3,264

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$554
Otsuka America Pharmaceutical, Inc.
$301
Teva Pharmaceuticals USA, Inc.
$286
ABBVIE INC.
$226
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$216
Vanda Pharmaceuticals Inc.
$193
Lundbeck LLC
$170
Bausch Health US, LLC
$147
Axsome Therapeutics, Inc.
$138
Alkermes, Inc.
$137
Indivior Inc.
$125
E.R. Squibb & Sons, L.L.C.
$100
Tris Pharma Inc
$83
IDORSIA PHARMACEUTICALS US INC
$81
Neurocrine Biosciences, Inc.
$40
Almatica Pharma LLC
$40
Takeda Pharmaceuticals U.S.A., Inc.
$39
Corium, LLC
$38
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$2,433
Otsuka America Pharmaceutical, Inc.
$1,636
Teva Pharmaceuticals USA, Inc.
$1,505
Lundbeck LLC
$1,351
Alkermes, Inc.
$1,041
ABBVIE INC.
$993
Sunovion Pharmaceuticals Inc.
$983
Vanda Pharmaceuticals Inc.
$938
Supernus Pharmaceuticals, Inc.
$742
Indivior Inc.
$569
ITI, Inc.
$533
Takeda Pharmaceuticals U.S.A., Inc.
$515
AbbVie Inc.
$431
Allergan Inc.
$425
Bausch Health US, LLC
$365
Allergan, Inc.
$332
IDORSIA PHARMACEUTICALS US INC
$327
Otsuka Pharmaceutical Development & Commercialization, Inc.
$281
Neurocrine Biosciences, Inc.
$271
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$216
Neos Therapeutics, LP
$148
Almatica Pharma LLC
$141
Axsome Therapeutics, Inc.
$138
Neuronetics, Inc.
$111
E.R. Squibb & Sons, L.L.C.
$100
Tris Pharma Inc
$97
Adlon Therapeutics L.P.
$71
Avanir Pharmaceuticals, Inc.
$57
Eisai Inc.
$48
Corium, LLC
$38
Merck Sharp & Dohme Corporation
$28
Alfasigma USA, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$17
Ironshore Pharmaceuticals Inc.
$14
Pernix Therapeutics Holdings, Inc.
$13
Noven Therapeutics, LLC
$11
Sumitomo Pharma America, Inc.
$9
Top 3 companies account for 32.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · CITALOPRAM · COBENFY · Dayvigo · Dyanavel XR · Evekeo · FANAPT · Fanapt · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · NEUROSTAR TMS THERAPY · NUEDEXTA · PERSERIS · QELBREE · QUVIVIQ · REXULTI · SECUADO · SERTRALINE HCL · SILENOR · SPRAVATO · TRINTELLIX · Trintellix · UZEDY · VRAYLAR · VYVANSE · Vivitrol · WELLBUTRIN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for psychiatry in CA.

Looking for a psychiatry specialist in Glendora?
Compare psychiatrists in the Glendora area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
619
Per 100K population
6.3
County median income
$87,760
Nearest hospital
EMANATE HEALTH FOOTHILL PRESBYTERIAN HOSPITAL
3.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gillespie is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gillespie experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Gillespie performed 2,218 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gillespie receive payments from pharmaceutical companies?
Yes. Dr. Gillespie received a total of $16,946 from 37 companies across 1,058 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gillespie's costs compare to other psychiatrists in Glendora?
Dr. Gillespie's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gillespie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →